Cancer Research

At Houston Methodist, our dedicated teams of world-renowned researchers help support the mission of our oncologists of bringing the latest technologies and advanced treatment options to patients as quickly and safely as possible. Our researchers conduct translational research and support numerous cancer-specific clinical trial protocols for brain, breast, liver, lung and many other forms of cancer.

Clinical and translational research plays a vital role in determining treatment plans at Houston Methodist and in bringing tomorrow's cures to our patients today. Explore the bridges between research and clinical care that have been built by our interdisciplinary faculty team and global network of collaborators.

COMBINING PAP AND HRHPV TESTS TO REDUCE CANCER MISS RATES

Houston Methodist study shows that co-testing with PAP and hrHPV would miss significantly fewer cervical cancers than either test performed alone. Learn More. 

Jenny C. Chang, MD

Jenny C. Chang, MD, is Professor of Cancer, the Emily Hermann Chair of Cancer Research, and the Division Chief of the Houston Methodist Cancer Center. Learn More.

INJECTABLE NANOPARTICLE GENERATOR FOR METASTATIC BREAST CANCER TREATMENT

Researchers from the Houston Methodist Research Institute have developed the first drug delivery system to successfully eliminate lung metastases in mice models with triple negative breast cancer. Learn more.

Nanoconstructs for Cancer Theranostics AND Targeted Delivery

Researchers have developed specialized nanoconstructs for targeted systemic delivery of imaging agents and therapeutic agents to cancer cells in the body. Learn More.